The functional interactions between the p53 and MAPK signaling pathways

Gen Sheng Wu1

  • 1Program in Molecular Biology and Human Genetics, Karmanos Cancer Institute, Department of Pathology, Wayne State University School of Medicine, Room E216, The Prentis Building, 110 East Warren Avenue, Detroit, Michigan 48201, USA. wug@karmanos.org

Cancer Biology & Therapy
|February 7, 2004
PubMed

Insights

The p53 protein interacts with mitogen-activated protein kinase (MAPK) pathways, influencing cell growth and apoptosis. Understanding this crosstalk is crucial for cancer research, as both pathways are frequently altered in tumors.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • The p53 tumor suppressor protein regulates cell growth and survival through diverse signaling pathways.
  • p53 activation, often by stress stimuli, involves phosphorylation by protein kinases and acts as a transcription factor.
  • Dysregulation of p53 and MAPK pathways is common in human cancers.

Purpose of the Study:

  • To explore the functional interactions between the p53 and mitogen-activated protein kinase (MAPK) signaling pathways.
  • To elucidate how these interactions contribute to cellular responses like cell cycle arrest and apoptosis.
  • To investigate the role of p53 in regulating MAPK signaling and vice versa.

Main Methods:

  • Review of existing literature on p53 and MAPK signaling.
  • Analysis of molecular mechanisms underlying p53-MAPK crosstalk.
  • Examination of transcriptional regulation of MAPK pathway components by p53.

Main Results:

  • p53 functionally interacts with MAPK pathways, including JNK, p38 MAPK, and ERK.
  • MAP kinases phosphorylate and activate p53 in response to stress, mediating cellular outcomes.
  • p53 can act as an upstream regulator of MAPK signaling through phosphatase gene activation.

Conclusions:

  • The interplay between p53 and MAPK signaling is a critical determinant of cell fate.
  • Understanding this crosstalk offers potential insights into deregulated proliferation and survival in cancer.
  • Targeting the p53-MAPK axis may represent a novel therapeutic strategy for cancer treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...